320 related articles for article (PubMed ID: 22546857)
21. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
[TBL] [Abstract][Full Text] [Related]
22. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
23. CD19 controls Toll-like receptor 9 responses in human B cells.
Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
[TBL] [Abstract][Full Text] [Related]
24. Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.
Shortt J; Martin BP; Newbold A; Hannan KM; Devlin JR; Baker AJ; Ralli R; Cullinane C; Schmitt CA; Reimann M; Hall MN; Wall M; Hannan RD; Pearson RB; McArthur GA; Johnstone RW
Blood; 2013 Apr; 121(15):2964-74. PubMed ID: 23403624
[TBL] [Abstract][Full Text] [Related]
25. Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation.
Calderón L; Schindler K; Malin SG; Schebesta A; Sun Q; Schwickert T; Alberti C; Fischer M; Jaritz M; Tagoh H; Ebert A; Minnich M; Liston A; Cochella L; Busslinger M
Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34301800
[TBL] [Abstract][Full Text] [Related]
26. The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model.
Amin R; Marfak A; Pangault C; Oblet C; Chanut A; Tarte K; Denizot Y; Cogné M
Oncotarget; 2014 Oct; 5(19):8995-9006. PubMed ID: 25229630
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement.
Inabe K; Kurosaki T
Blood; 2002 Jan; 99(2):584-9. PubMed ID: 11781242
[TBL] [Abstract][Full Text] [Related]
28. Pre-germinal center origin for mature mouse B cell lymphomas: a major discrepancy with human mature lymphomas.
Saintamand A; Garot A; Saad F; Moulinas R; Denizot Y
Cell Cycle; 2015; 14(22):3656-8. PubMed ID: 26654599
[No Abstract] [Full Text] [Related]
29. Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.
Moyo TK; Wilson CS; Moore DJ; Eischen CM
Oncogene; 2017 Aug; 36(32):4653-4661. PubMed ID: 28368423
[TBL] [Abstract][Full Text] [Related]
30. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
31. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
[TBL] [Abstract][Full Text] [Related]
32. Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.
Bharti B; Shukla S; Tripathi R; Mishra S; Kumar M; Pandey M; Mishra R
Indian J Med Res; 2016 May; 143(Supplement):S23-S31. PubMed ID: 27748274
[TBL] [Abstract][Full Text] [Related]
33. Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice.
Gerbitz A; Sukumar M; Helm F; Wilke A; Friese C; Fahrenwaldt C; Lehmann FM; Loddenkemper C; Kammertoens T; Mautner J; Schmitt CA; Blankenstein T; Bornkamm GW
PLoS One; 2012; 7(3):e34552. PubMed ID: 22479645
[TBL] [Abstract][Full Text] [Related]
34. Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene.
Lefebure M; Tothill RW; Kruse E; Hawkins ED; Shortt J; Matthews GM; Gregory GP; Martin BP; Kelly MJ; Todorovski I; Doyle MA; Lupat R; Li J; Schroeder J; Wall M; Craig S; Poortinga G; Cameron D; Bywater M; Kats L; Gearhart MD; Bardwell VJ; Dickins RA; Hannan RD; Papenfuss AT; Johnstone RW
Nat Commun; 2017 Mar; 8():14581. PubMed ID: 28262675
[TBL] [Abstract][Full Text] [Related]
35. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
[TBL] [Abstract][Full Text] [Related]
36. CD19, from bench to bedside.
Li X; Ding Y; Zi M; Sun L; Zhang W; Chen S; Xu Y
Immunol Lett; 2017 Mar; 183():86-95. PubMed ID: 28153605
[TBL] [Abstract][Full Text] [Related]
37. CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes.
Dasu T; Sindhava V; Clarke SH; Bondada S
Mol Immunol; 2009 Aug; 46(13):2655-65. PubMed ID: 19541367
[TBL] [Abstract][Full Text] [Related]
38. The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma cells.
Beckwith M; Jorgensen G; Longo DL
Blood; 1996 Nov; 88(9):3502-7. PubMed ID: 8896416
[TBL] [Abstract][Full Text] [Related]
39. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
[TBL] [Abstract][Full Text] [Related]
40. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex.
Bullerwell CE; Robichaud PP; Deprez PML; Joy AP; Wajnberg G; D'Souza D; Chacko S; Fournier S; Crapoulet N; Barnett DA; Lewis SM; Ouellette RJ
Sci Rep; 2021 Jan; 11(1):1537. PubMed ID: 33452395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
